Draft Guidance for Industry on Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted under an ANDA; Availability

1 organizations filed 1 public comment on Draft Guidance for Industry on Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted under an ANDA; Availability, at the Food and Drug Administration. The comment window closed 1740d ago.

Commenters (1)

• Association for Accessible Medicinestrade assoc.

  1 filing · confidence 97%